Seeking Alpha

  Arrowhead Research Corporation (ARWR) - NASDAQ

  • Jim Van Meerten | Send Message 7 Nov 2011

    ARWR - 80% Barchart technical buy signal - 18 new highs and up 53.85% in the last month - Relative strngth Index 70.73% and rising
      ARWR vs. ETF Alternatives
      Company Description
      Arrowhead Research Corp is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company's drug candidate ARC-520 is designed to treat chronic hepatitis B infection.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States